Pierre FUMOLEAU is since july 2017 Director of the Curie Institute (Paris). He was previously CEO of the Dijon comprehensive cancer center (Georges-François Leclerc center). He also is PUPH in medical oncology at the University of Burgundy, Vice-President and Secretary of Unicancer steering committee, President of the Bourgundy/Franche-Comté scientific co-operation foundation and co-driver for the care paths with the Burgundy Regional Health Agency. After receiving his medical degree in 1979 and graduating in medical oncology in Nantes, he has held throughout his career various responsabilities within healthcare institutions and academic structures in the Burgundy and Franche-Comté regions of France.
Member of several scientific committeesn he also was general secretary of the European Organisation for Research and Treatment of Cancer (EORTC) from 2003 to 2006. Heavily involved in clinical and translationnal research, particularly in breast cancer, he is a recognized expert in new anti cancer agents early development and an active member in many groups.
Profesor Pierre Fumoleau took over MATWIN presidency after Profesor Josy Reiffers died in 2015. Profesor Josy Reiffers was MATWIN programme first president and founder from 2009 to 2015.
Lucia Robert has over 20 years of professional experience linked to the promotion of research results. With a good knowledge of the processes and players in technology transfer, she has been managing and operational management of the MATWIN platform for almost 10 years as well as all industrial and institutional partnerships.
Through multidisciplinary leadership experience in both the private and public sectors, Lucia has developed recognized expertise in the management of transfer activities and public-private partnerships (public establishments, industrial partners, investors). After having created then directed the research valorization service of the University of Bordeaux 2, Lucia then put her skills and her network at the service of the City of Bordeaux, then ended up taking the direction of MATWIN in 2010 to coordinate the nationwide program and enable its international development.
Emmanuel Conseiller is a professional of innovation in life sciences with a strong leadership experience (25 years) in drug discovery and diagnostic test development in Pharmaceutical industry and in Biotech.
He developed a recognized expertise in oncology, genomics and genetics, translational research and personalized medicine with many track records in strategic integration of diverse scientific information, implementation of innovative life science technologies and approaches, interfacing private and academic research and in technology transfer.
Graduate in Pharmacy from the university of Poitiers, with a specialised master in Biopharmaceutical management from the ESCP business school, Charlène Herbert joined the team as Projects Manager in November 2020 to support MATWIN’s projects, and help develop the program.
Over the past three years, Charlène has already put her experience at the service of the medical departments of the French subsidiaries of Roche and then Ipsen in the fields of neurology and oncology. She then moved to Boston (USA) to work at Sanofi Genzyme’s headquarters in the field of immunology, strengthening her knowledge in drug development.
With a Bachelor of business administration degree, Stéphanie Dhont improved her foreign languages skills through various long stays abroad (England, Mexico, United States) She has experienced many different jobs in various areas from hotel industry to video games or even transportations. Very polyvalent, she joined MATWIN team in late 2014 as management assistant. She is managing administration and accounting, as well as communication and and events organization.